M.B. Best Medical Group, INC.
M.B. Best Medical Group, INC. was paid $9.28M by Medicaid between Jan 2018 and Jul 2024, across 57 billing codes. Its largest line is 95165, Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials — 37% of everything it billed.
33Billing provider infoM.B. BEST MEDICAL GROUP, INC.
PHOENIX, AZ 85051
PHOENIX, AZ 85051
33aNPI1891834552assigned 02/06/2007
33bProvider typeAudiologist
28Total paid$9.28M
24GClaims109,850
24DCodes billed57
24AFirst – last monthJan 2018 – Jul 2024
Compared with peers
Next to other Audiologist providers in Arizona
Rank by total paid#2 of 9
Median peer was paid$92K
This provider vs. median100×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,205 | $330K | |
| 2019 | 13,200 | $340K | |
| 2020 | 15,657 | $1.22M | |
| 2021 | 28,980 | $2.63M | |
| 2022 | 31,286 | $3.00M | |
| 2023 | 10,851 | $1.57M | |
| 2024incomplete | 1,671 | $196K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 37% | 16,274 | 2,655 | $3.48M |
| 95144 | 35% | 26,783 | 4,046 | $3.25M | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.2% | 11,145 | 9,227 | $671K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.6% | 14,788 | 11,918 | $616K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 4.6% | 2,033 | 2,002 | $429K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.3% | 2,966 | 2,763 | $211K |
| 87428 | 2.0% | 4,108 | 3,225 | $183K | |
| 95923 | <1% | 903 | 872 | $85K | |
| 95943 | <1% | 609 | 587 | $72K | |
| 93923 | <1% | 701 | 674 | $63K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 463 | 410 | $26K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 595 | 273 | $24K |
45 more codes
| L0637 | Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 21 | $19K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,115 | $19K |
| 95921 | <1% | 289 | $18K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 594 | $14K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 596 | $13K |
| 94760 | <1% | 16,490 | $12K | |
| 95886 | <1% | 72 | $10K | |
| 96138 | <1% | 469 | $8K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 69 | $7K |
| 99000 | <1% | 2,311 | $7K | |
| 93922 | <1% | 98 | $6K | |
| 95913 | <1% | 33 | $6K | |
| 93000 | <1% | 504 | $6K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 29 | $4K |
| 99457 | <1% | 69 | $3K | |
| 97161 | <1% | 42 | $2K | |
| 82962 | <1% | 1,064 | $2K | |
| 99490 | Ccm add 20min | <1% | 570 | $1K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 14 | $1K |
| 90658 | <1% | 133 | $1K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 16 | $920.95 |
| G0008 | Administration of influenza virus vaccine | <1% | 145 | $777.36 |
| 99454 | <1% | 20 | $631.62 | |
| 87486 | <1% | 26 | $598.48 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 42 | $537.34 |
| 0012A | <1% | 14 | $486.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 32 | $479.30 |
| 87500 | <1% | 21 | $444.48 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 30 | $419.25 |
| 99439 | <1% | 139 | $354.58 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 295 | $235.83 |
| 80306 | <1% | 120 | $217.67 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 14 | $216.64 |
| 99453 | <1% | 16 | $141.30 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 97 | $89.81 |
| 96127 | <1% | 68 | $76.59 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 34 | $65.89 |
| A6451 | Moderate compression bandage, elastic, knitted/woven, load resistance of 1.25 to 1.34 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard | <1% | 38 | $54.20 |
| G2058 | Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). | <1% | 21 | $37.35 |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | <1% | 64 | $24.78 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 104 | $7.58 |
| 98960 | 0% | 2,456 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 14 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 14 | $0.00 |
| 97010 | 0% | 60 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLANCHIAN, ALBERT (MANAGER)